Sumitomo Mitsui Trust Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $409M | Sell |
2,931,232
-337,885
| -10% | -$47.3M | 0.26% | 74 |
|
|
2025
Q4 | $401M | Sell |
3,269,117
-60,405
| -2% | -$7.34M | 0.24% | 79 |
|
|
2025
Q3 | $370M | Buy |
3,329,522
+27,232
| +0.8% | +$3.1M | 0.21% | 95 |
|
|
2025
Q2 | $366M | Buy |
3,302,290
+211,097
| +7% | +$22.5M | 0.23% | 92 |
|
|
2025
Q1 | $346M | Buy |
3,091,193
+57,133
| +2% | +$5.9M | 0.24% | 85 |
|
|
2024
Q4 | $280M | Buy |
3,034,060
+10,076
| +0.3% | +$907K | 0.19% | 104 |
|
|
2024
Q3 | $254M | Buy |
3,023,984
+55,841
| +2% | +$4.26M | 0.18% | 120 |
|
|
2024
Q2 | $204M | Sell |
2,968,143
-516,559
| -15% | -$34.5M | 0.15% | 138 |
|
|
2024
Q1 | $255M | Buy |
3,484,702
+10,218
| +0.3% | +$786K | 0.18% | 123 |
|
|
2023
Q4 | $281M | Buy |
3,474,484
+57,537
| +2% | +$4.48M | 0.21% | 103 |
|
|
2023
Q3 | $256M | Sell |
3,416,947
-36,950
| -1% | -$2.84M | 0.21% | 102 |
|
|
2023
Q2 | $266M | Sell |
3,453,897
-434,927
| -11% | -$34.7M | 0.21% | 101 |
|
|
2023
Q1 | $323M | Sell |
3,888,824
-362,712
| -9% | -$30M | 0.24% | 92 |
|
|
2022
Q4 | $365M | Sell |
4,251,536
-245,057
| -5% | -$19.4M | 0.29% | 76 |
|
|
2022
Q3 | $277M | Buy |
4,496,593
+16,079
| +0.4% | +$1.01M | 0.23% | 102 |
|
|
2022
Q2 | $277M | Sell |
4,480,514
-34,519
| -0.8% | -$2.14M | 0.21% | 99 |
|
|
2022
Q1 | $268M | Sell |
4,515,033
-8,306
| -0.2% | -$531K | 0.18% | 120 |
|
|
2021
Q4 | $328M | Buy |
4,523,339
+583,717
| +15% | +$40.2M | 0.2% | 111 |
|
|
2021
Q3 | $275M | Sell |
3,939,622
-195,808
| -5% | -$13.8M | 0.17% | 127 |
|
|
2021
Q2 | $285M | Sell |
4,135,430
-681,373
| -14% | -$45.5M | 0.17% | 135 |
|
|
2021
Q1 | $311M | Sell |
4,816,803
-245,343
| -5% | -$15.8M | 0.19% | 114 |
|
|
2020
Q4 | $295M | Sell |
5,062,146
-633,599
| -11% | -$38.2M | 0.19% | 122 |
|
|
2020
Q3 | $360M | Sell |
5,695,745
-43,074
| -0.8% | -$2.99M | 0.24% | 88 |
|
|
2020
Q2 | $442M | Buy |
5,738,819
+473,677
| +9% | +$36.3M | 0.31% | 63 |
|
|
2020
Q1 | $394M | Buy |
5,265,142
+32,841
| +0.6% | +$2.27M | 0.34% | 63 |
|
|
2019
Q4 | $340M | Buy |
5,232,301
+77,087
| +1% | +$5.02M | 0.27% | 79 |
|
|
2019
Q3 | $327M | Buy |
5,155,214
+54,910
| +1% | +$3.59M | 0.28% | 72 |
|
|
2019
Q2 | $345M | Sell |
5,100,304
-113,456
| -2% | -$7.46M | 0.31% | 68 |
|
|
2019
Q1 | $339M | Buy |
5,213,760
+167,292
| +3% | +$11.1M | 0.31% | 70 |
|
|
2018
Q4 | $312M | Buy |
5,046,468
+800,268
| +19% | +$55.9M | 0.34% | 66 |
|
|
2018
Q3 | $328M | Buy |
4,246,200
+68,555
| +2% | +$5.18M | 0.35% | 61 |
|
|
2018
Q2 | $296M | Buy |
4,177,645
+275,803
| +7% | +$19.5M | 0.34% | 62 |
|
|
2018
Q1 | $294M | Buy |
3,901,842
+56,537
| +1% | +$4.49M | 0.38% | 61 |
|
|
2017
Q4 | $275M | Buy |
3,845,305
+74,410
| +2% | +$5.65M | 0.36% | 57 |
|
|
2017
Q3 | $306M | Sell |
3,770,895
-47,702
| -1% | -$3.65M | 0.43% | 47 |
|
|
2017
Q2 | $270M | Buy |
3,818,597
+37,493
| +1% | +$2.49M | 0.4% | 48 |
|
|
2017
Q1 | $257M | Sell |
3,781,104
-3,132
| -0.1% | -$220K | 0.4% | 49 |
|
|
2016
Q4 | $271M | Sell |
3,784,236
-81,656
| -2% | -$6.07M | 0.44% | 47 |
|
|
2016
Q3 | $306M | Sell |
3,865,892
-86,644
| -2% | -$7.04M | 0.5% | 40 |
|
|
2016
Q2 | $330M | Sell |
3,952,536
-487,862
| -11% | -$43.3M | 0.57% | 38 |
|
|
2016
Q1 | $408M | Buy |
4,440,398
+88,404
| +2% | +$7.97M | 0.71% | 29 |
|
|
2015
Q4 | $445M | Sell |
4,351,994
-20,664
| -0.5% | -$2.15M | 0.79% | 24 |
|
|
2015
Q3 | $429M | Buy |
4,372,658
+86,474
| +2% | +$9.6M | 0.83% | 21 |
|
|
2015
Q2 | $502M | Sell |
4,286,184
-55,801
| -1% | -$6.1M | 0.9% | 16 |
|
|
2015
Q1 | $426M | Buy |
4,341,985
+380,136
| +10% | +$38.6M | 0.77% | 21 |
|
|
2014
Q4 | $377M | Sell |
3,961,849
-83,343
| -2% | -$8.62M | 0.73% | 24 |
|
|
2014
Q3 | $431M | Sell |
4,045,192
-76,900
| -2% | -$7.53M | 0.86% | 16 |
|
|
2014
Q2 | $342M | Sell |
4,122,092
-234,408
| -5% | -$18.2M | 0.7% | 24 |
|
|
2014
Q1 | $309M | Sell |
4,356,500
-23,873
| -0.5% | -$1.87M | 0.65% | 31 |
|
|
2013
Q4 | $329M | Buy |
4,380,373
+137,013
| +3% | +$9.54M | 0.68% | 31 |
|
|
2013
Q3 | $267M | Sell |
4,243,360
-9,220
| -0.2% | -$551K | 0.58% | 33 |
|
|
2013
Q2 | $218M | Buy |
+4,252,580
| New | +$222M | 0.49% | 37 |
|
Other funds holding GILD
VCM
VPM
Sumitomo Mitsui Trust Group's GILD Position: Q1 2026 in Review
Sumitomo Mitsui Trust Group reduced its Gilead Sciences (GILD) stake by 10% in Q1 2026, selling an estimated $47.3M and leaving 2,931,232 shares worth $409M. The position accounts for 0.26% of the portfolio, ranked #74.
Sumitomo Mitsui Trust Group first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $502M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Sumitomo Mitsui Trust Group held 2,931,232 shares of Gilead Sciences worth $409M as of Q1 2026.
- Sumitomo Mitsui Trust Group sold 337,885 Gilead Sciences shares in Q1 2026, an estimated $47.3M.
- Gilead Sciences made up 0.26% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #74 holding.
- Sumitomo Mitsui Trust Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Sumitomo Mitsui Trust Group's Gilead Sciences position peaked at $502M in Q2 2015.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.